perhexiline maleate

03/01/1981 - "Single-dose pharmacokinetic studies were performed with 150- and 300-mg oral doses of perhexiline maleate in five patients with severe angina pectoris and impaired left ventricular function. "
12/01/1976 - "[Multicentric study with perhexiline maleate in angina pectoris. "
09/01/1976 - "Report of a multicentre monitored release study of perhexiline maleate in the prevention of angina pectoris."
02/28/1976 - "A double-blind trial of perhexiline maleate in the prophylaxis of angina pectoris."
04/01/1973 - "Proceedings: Perhexiline maleate in the treatment of angina pectoris: a double-blind trial."

11/27/1978 - "The present study is a comparison of the pharmacokinetics of perhexiline maleate in anginal patients with and without signs of peripheral neuropathy. "
05/01/1979 - "Perhexiline maleate and peripheral neuropathy."
11/27/1978 - "Thus, peripheral neuropathy associated with perhexiline maleate treatment appears to be a direct toxic effect due to accumulation of the drug. "
11/27/1978 - "Pharmacokinetics of perhexiline maleate in anginal patients with and without peripheral neuropathy."
11/01/1977 - "[Peripheral neuropathies due to perhexiline maleate (author's transl)]."

08/01/1973 - "Assessment of perhexiline maleate in ischaemic heart disease."
11/29/1975 - "In a preliminary study which lasted 14 weeks, an anti-anginal preparation, perhexiline maleate (Pexid), was prescribed in a dosage of 200 mg twice a day to 7 patients who were suffering from cardiac arrhythmias associated with ischaemic heart disease. "
11/29/1975 - "The anti-arrhythmic effects of perhexiline maleate in patients with ischaemic heart disease."
12/16/1978 - "The anti-arrhythmic efficacy of perhexiline maleate, disopyramide and mexiletine has been evaluated in 27 patients with chronic ischaemic heart disease who exhibited frequent ventricular ectopic beats (i.e. "

12/16/1978 - "The anti-arrhythmic efficacy of perhexiline maleate, disopyramide and mexiletine has been evaluated in 27 patients with chronic ischaemic heart disease who exhibited frequent ventricular ectopic beats (i.e. "

10/16/2013 - "By the drug repositioning strategy, we confirmed that perhexiline maleate (Pex) potentially ameliorates heterotopic ossification in model cells and mice. "